Specifically, Swiss individuals that mapped to Subtype 3 exhibited low Aβ levels, consistent with AD-like Subtypes 4, 5, and 6, while their tau levels aligned more closely with the control-like Subtypes 1 and 2 (Fig. 5C). Here, MAPT is linked to Alzheimer disease.